SCHEMBL67956

SCHEMBL67956

Brc1c[nH]c(Br)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18886217 0.67 — —
SCHEMBL6246411 0.66 CSNK2A1 (0.36) —
SCHEMBL9958531 0.66 — —
SCHEMBL16769633 0.66 — —
SCHEMBL18556320 0.66 — —
SCHEMBL9814675 0.66 ALDH1A1 (0.30) —
SCHEMBL3103074 0.66 — —
SCHEMBL3103852 0.66 — —
SCHEMBL3108444 0.66 — —
SCHEMBL3105669 0.64 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 114 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118767697-B Porous membrane for asymmetric all-vanadium redox flow battery and preparation method thereof 杭州德海艾科能源科技有限公司 2024-11-19 — — CN claimed
CN-118767697-A Porous membrane for asymmetric all-vanadium redox flow battery and preparation method thereof 杭州德海艾科能源科技有限公司 2024-10-15 — — CN claimed
WO-2023122498-A1 ONE-STEP OXIDE BATH FOR IMPROVING ADHESION OF POLYMERIC MATERIALS TO METAL SUBSTRATES MACDERMID, INCORPORATED (US) 2023-06-29 — — WO claimed
US-20230199972-A1 One-Step Oxide Bath for Improving Adhesion of Polymeric Materials to Metal Substrates MACDERMID, INCORPORATED 2023-06-22 — — US claimed
US-4662905-A REACTION PRODUCT OF COPPER SALT AND AN IMIDAZOLE, PYRAZOLE, TRIAZOLE, OR TETRAZOLE Itaru Todoriki, Director of Agency of Industrial Science and Technology (JP) 1987-05-05 — — US claimed
US-12404274-B2 Macrocycles as factor xia inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2025-09-02 — — US disclosed
US-12398122-B2 Resolvin analogs compounds, methods and uses thereof VALORISATION RECHERCHE HSCM LIMITED PARTNERSHIP (CA) 2025-08-26 — — US disclosed
CN-120129686-A Method for preparing compound with bi-branched N-acetyl-D-galactosamine structure 第一三共株式会社 2025-06-10 — — CN disclosed
US-20250115588-A1 RESOLVIN ANALOGS COMPOUNDS, METHODS AND USES THEREOF VALORISATION RECHERCHE HSCM, LIMITED PARTNERSHIP (CA) 2025-04-10 — — US disclosed
US-12264159-B2 Functionalized heterocycles as antiviral agents ENANTA PHARMACEUTICALS, INC. (US) 2025-04-01 — — US disclosed
EP-4466263-A1 RESOLVIN ANALOGS COMPOUNDS, METHODS AND USES THEREOF Valorisation Recherche HSCM, Limited Partnership (CA) 2024-11-27 — — EP disclosed
CN-118767697-B Porous membrane for asymmetric all-vanadium redox flow battery and preparation method thereof 杭州德海艾科能源科技有限公司 2024-11-19 — — CN disclosed
US-5719140-A ANALGESICS, PROSTAGLANDIN-E2 ANTAGONISTS G.D. SEARLE & CO. (US) 1998-02-17 — — US disclosed
EP-0696283-B1 2-, 3-, 4-, 5-, 6-, 7-, 8-, 9- AND/OR 10-SUBSTITUTED DIBENZOXAZEPINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE SEARLE & CO (US) 1997-09-17 — — EP disclosed
EP-0696283-A1 2-, 3-, 4-, 5-, 6-, 7-, 8-, 9- AND/OR 10-SUBSTITUTED DIBENZOXAZEPINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE SEARLE & CO (US) 1996-02-14 — — EP disclosed
US-5395932-A Analgesics, prostaglandin E2 inhibitors G. D. SEARLE & CO. (US) 1995-03-07 — — US disclosed
WO-1994025456-A1 2-, 3-, 4-, 5-, 6-, 7-, 8-, 9- AND/OR 10-SUBSTITUTED DIBENZOXAZEPINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE G.D. SEARLE & CO. (US) 1994-11-10 — — WO disclosed
US-4662905-A REACTION PRODUCT OF COPPER SALT AND AN IMIDAZOLE, PYRAZOLE, TRIAZOLE, OR TETRAZOLE Itaru Todoriki, Director of Agency of Industrial Science and Technology (JP) 1987-05-05 — — US disclosed
US-4161571-A GELATION INHIBITORS SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1979-07-17 — — US disclosed
US-4080493-A POLYBUTADIENE, POLYISOPRENE, GELATION INHIBITOR SUMITOMO CHEMICAL COMPANY, LIMITED (JA) 1978-03-21 — — US disclosed
Send feedback